Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Kurth

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Clinical Neuropharmacology|May 10, 2000
Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonismK M Jorga, T L Davis, M C Kurth, et al.
Neuroepidemiology|May 21, 1998
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementiaJ P Hubble, J H Kurth, S L Glatt, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot studyW J Tremaine, A Brzezinski, J A Katz, et al.
Epilepsy & Behavior : E&B|February 2, 2016
Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in GermanyR D Nass, C Kurth, A Kull, et al.
Parkinsonism & Related Disorders|October 1, 1996
Prevalence of tremor and Parkinson's diseaseA S Khatter, M C Kurth, M A Brewer, et al.
National Science Review|April 5, 2024
Modular-integrative modeling: a new framework for building brain models that blend biological realism and functional performanceMario Senden, Sacha J van Albada, Giovanni Pezzulo, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Clinical Neuropharmacology|May 10, 2000
Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonismK M Jorga, T L Davis, M C Kurth, et al.
Neuroepidemiology|May 21, 1998
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementiaJ P Hubble, J H Kurth, S L Glatt, et al.
Neurology|January 1, 1997
Tolcapone improves motor function and reduces levodopa requirement in patients with Parkinson's disease experiencing motor fluctuations: a multicenter, double-blind, randomized, placebo-controlled trial. Tolcapone Fluctuator Study Group IM C Kurth, C H Adler, M S Hilaire, et al.
Alimentary Pharmacology & Therapeutics|March 6, 2002
Treatment of mildly to moderately active ulcerative colitis with a tryptase inhibitor (APC 2059): an open-label pilot studyW J Tremaine, A Brzezinski, J A Katz, et al.
Epilepsy & Behavior : E&B|February 2, 2016
Adjunctive retigabine in refractory focal epilepsy: Postmarketing experience at four tertiary epilepsy care centers in GermanyR D Nass, C Kurth, A Kull, et al.
Parkinsonism & Related Disorders|October 1, 1996
Prevalence of tremor and Parkinson's diseaseA S Khatter, M C Kurth, M A Brewer, et al.
National Science Review|April 5, 2024
Modular-integrative modeling: a new framework for building brain models that blend biological realism and functional performanceMario Senden, Sacha J van Albada, Giovanni Pezzulo, et al.
Pageof 5